1. Home
  2. KVHI vs CRBP Comparison

KVHI vs CRBP Comparison

Compare KVHI & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVHI
  • CRBP
  • Stock Information
  • Founded
  • KVHI 1978
  • CRBP 2009
  • Country
  • KVHI United States
  • CRBP United States
  • Employees
  • KVHI N/A
  • CRBP N/A
  • Industry
  • KVHI Radio And Television Broadcasting And Communications Equipment
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • KVHI Technology
  • CRBP Health Care
  • Exchange
  • KVHI Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • KVHI 119.2M
  • CRBP 114.8M
  • IPO Year
  • KVHI 1996
  • CRBP N/A
  • Fundamental
  • Price
  • KVHI $6.14
  • CRBP $9.37
  • Analyst Decision
  • KVHI
  • CRBP Strong Buy
  • Analyst Count
  • KVHI 0
  • CRBP 10
  • Target Price
  • KVHI N/A
  • CRBP $53.22
  • AVG Volume (30 Days)
  • KVHI 31.7K
  • CRBP 91.8K
  • Earning Date
  • KVHI 11-06-2025
  • CRBP 11-06-2025
  • Dividend Yield
  • KVHI N/A
  • CRBP N/A
  • EPS Growth
  • KVHI N/A
  • CRBP N/A
  • EPS
  • KVHI N/A
  • CRBP N/A
  • Revenue
  • KVHI $107,925,000.00
  • CRBP N/A
  • Revenue This Year
  • KVHI N/A
  • CRBP N/A
  • Revenue Next Year
  • KVHI $14.15
  • CRBP $220.04
  • P/E Ratio
  • KVHI N/A
  • CRBP N/A
  • Revenue Growth
  • KVHI N/A
  • CRBP N/A
  • 52 Week Low
  • KVHI $4.35
  • CRBP $4.64
  • 52 Week High
  • KVHI $6.37
  • CRBP $56.93
  • Technical
  • Relative Strength Index (RSI)
  • KVHI 65.37
  • CRBP 47.64
  • Support Level
  • KVHI $5.74
  • CRBP $9.42
  • Resistance Level
  • KVHI $6.31
  • CRBP $9.73
  • Average True Range (ATR)
  • KVHI 0.26
  • CRBP 0.49
  • MACD
  • KVHI 0.03
  • CRBP -0.09
  • Stochastic Oscillator
  • KVHI 77.45
  • CRBP 19.37

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: